Profile picture

Doctor Iulia Rodionova

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)
Follow
Logo ESC

Contributor content

Myeloperoxidase as a prognostic marker for adverse events in patients with chronic heart failure in 12 month follow-up
Presentation
Myeloperoxidase as a prognostic marker for adverse events in patients with chronic heart failure in 12 month follow-up
sST2 association with atrial fibrillation development in patients with acute myocardial infarction with ST elevation
Presentation
sST2 association with atrial fibrillation development in patients with acute myocardial infarction with ST elevation
The optimization of dual antiplatelet therapy in patients with ST-segment elevation myocardial infarction in dependence on the vasculoendothelial growth factor-A gene polymorphism G634C (rs2010963)
Presentation
The optimization of dual antiplatelet therapy in patients with ST-segment elevation myocardial infarction in dependence on the vasculoendothelial growth factor-A gene polymorphism G634C (rs2010963)
Comparison of eplerenone and spyronolacton effects in prevention of left ventricular remodeling and development of heart failure in patients after STEMI
Presentation
Comparison of eplerenone and spyronolacton effects in prevention of left ventricular remodeling and development of heart failure in patients after STEMI
VEGF-A gene polymorphism and VEGF-A level association with the development of heart failure in patients with ST-elevation myocardial infarction
Presentation
VEGF-A gene polymorphism and VEGF-A level association with the development of heart failure in patients with ST-elevation myocardial infarction

ESC 365 is supported by